529,535 Shares in Oaktree Acquisition Corp. III Life Sciences $OACC Acquired by Goldman Sachs Group Inc.

Key Points

• Goldman Sachs Group Inc. acquired 529,535 shares of Oaktree Acquisition Corp. III Life Sciences, valued at approximately $5,417,000, giving them a 2.36% stake in the company.
• Other institutional investors have also increased their stakes, with notable purchases from firms including DLD Asset Management LP and Driehaus Capital Management LLC, highlighting growing interest in the SPAC.
• Oaktree Acquisition Corp. III Life Sciences shares opened at $10.49, experiencing a 1-year low of $9.95 and a high of $10.85, indicating stable price performance within this range.

Goldman Sachs Group Inc. bought a new position in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 529,535 shares of the company's stock, valued at approximately $5,417,000. Goldman Sachs Group Inc. owned approximately 2.36% of Oaktree Acquisition Corp. III Life Sciences at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the stock. DLD Asset Management LP grew its holdings in Oaktree Acquisition Corp. III Life Sciences by 100.0% during the 1st quarter. DLD Asset Management LP now owns 350,000 shares of the company's stock valued at $3,580,000 after buying an additional 175,000 shares in the last quarter. Millennium Management LLC purchased a new stake in Oaktree Acquisition Corp. III Life Sciences during the 1st quarter valued at approximately $4,848,000. Ghisallo Capital Management LLC purchased a new stake in Oaktree Acquisition Corp. III Life Sciences during the 1st quarter valued at approximately $4,590,000. Linden Advisors LP purchased a new stake in Oaktree Acquisition Corp. III Life Sciences during the 1st quarter valued at approximately $6,120,000. Finally, Driehaus Capital Management LLC purchased a new stake in Oaktree Acquisition Corp. III Life Sciences during the 1st quarter valued at approximately $9,180,000.

Oaktree Acquisition Corp. III Life Sciences Price Performance

Shares of OACC opened at $10.49 on Tuesday. Oaktree Acquisition Corp. III Life Sciences has a 1 year low of $9.95 and a 1 year high of $10.85. The company has a 50 day simple moving average of $10.44 and a two-hundred day simple moving average of $10.36.

Oaktree Acquisition Corp. III Life Sciences Company Profile

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.